As an equity shareholder, we are committed to helping our portfolio companies succeed:
+ Support from Venture Partners & Business Partners
Portfolio companies enjoy extensive support from VBI’s Venture Partners who are all senior scientists, industry specialists, and fellow biotech entrepreneurs. Founders can also receive business and management assistance from seasoned experts.
VBI can assist with the distribution of news and updates to help facilitate future financing and outreach.
+ Lab and Office Space
Viva Biotech has 3+ incubators located in Shanghai, Chengdu, and Jiaxing with a satellite office in Boston.
+ Later Stage Funding Introductions
VBI can serve as a source of future connections and financing through our ever-growing network and syndicate of investors throughout China and the US.
+ Financial Advising
VBI’s wealth of experience helps us to work with our portfolio companies so they can remain on track and within their budgets while being able to pull in new sources of funding.
+ Admin Logistics
VBI can provide a full suite of back office services and expertise to make startup operations as smooth as possible.
This new generation of uric acid excretion enhancers is currently in Phase 1 clinical studies. The aim is to reduce the frequency of gout attacks and dissolve gout stones, thereby replacing the current market for gout drugs.MORE >
Dogma is a biotechnology startup developing a small molecule compound to lower cholesterol (first-in-class). Viva is incubating Dogma and will obtain equity in the company for providing early drug discovery services to Dogma.MORE >